http://www.fpnotebook.com/
Mild Persistent Asthma
Aka: Mild Persistent Asthma, Mild Asthma
- See Also
- Asthma
- Asthma Evaluation
- Asthma Education
- Asthma Management
- Mild Intermittent Asthma
- Moderate Persistent Asthma
- Severe Persistent Asthma
- Criteria
- Frequent exacerbations (>2x/week) but not daily
- Exacerbations may affect activity
- Nocturnal symptoms more than twice per month
- Pulmonary Function Test Criteria
- FEV1 or PEF > 80% predicted
- PEF variability 20-30%
- Management
- Long-term control with one Anti-Inflammatory medication
- Inhaled Corticosteroid (Low Dose)
- Inhaled Cromolyn or Nedocromil
- Do not substitute with Long-acting Beta Agonist
- Risks loss of Asthma control
- Steroids are key management of persistent Asthma
- Long-acting Beta Agonist is in addition to steroids
- Lazarus (2001) JAMA 285:2583-93
- Adult stable patients may taper steroids to half dose
- Hawkins (2003) BMJ 326:1115
- Short-term
- Rescue with beta agonist
- Increased use may indicate Moderate Persistent Asthma
- Asthma Education
- Consider Group education
- Management: As needed Inhaled Corticosteroids
- Indications
- Mild Persistent Asthma well controlled on a low-dose Corticosteroid
- Contraindications (and reason to return back to daily Inhaled Corticosteroids)
- Albuterol inhaler use more than twice weekly
- Advantages
- May offer similar Asthma control with only one-half total Inhaled Corticosteroid dose
- Protocol
- Discontinue daily Inhaled Corticosteroid
- Use 2 puffs of the Inhaled Corticosteroid at the same time as the rescue inhaler
- Return to daily Inhaled Corticosteroid use if rescue inhaler used more than twice weekly
- References
- Boushey (2005) N Engl J Med 352(15):1519-28
- Martinez (2011) Lancet 377(9766):650-7
- Papi (2007) N Engl J Med 356(20):2040-52
- References
- (1997) Management of Asthma, NIH 97-4053
- (1995) Global Strategy for Asthma, NIH 95-3659
- Kalister (2001) West J Med 174:415-20
- Kemp (2001) Am Fam Physician 63(7):1341-54